If authorised, the changes would mark the first major retooling of Covid vaccines, but also could slow their rollout as the ...
The FDA said that it won't require vaccine makers to conduct lengthy clinical trials for COVID-19 boosters, and will instead use data from historical trials and other sources.
In the months that followed the Provincetown outbreak, breakthrough infections would shift from a statistical anomaly to a ...
ABC1h
Health insurers and self-insured employers must post prices they have negotiated with providers; Senate Democrats draft a ...
This fall, vaccine makers will begin rolling out coronavirus booster vaccines better tailored to fight the current phase of ...
In anticipation of a new surge of COVID-19 infections later this year, the FDA recommends that COVID-19 vaccine manufacturers ...
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss t ...
The milder disease Omicron variants cause and doubt that older vaccines may not work for newer strains has led many to forgo ...
Deepak Bhurtel, a local from Ward 15 of Kathmandu Metropolitan City, accompanied his daughter Sambhabi to her school, ...
The available COVID-19 vaccines are currently fully approved or approved for emergency use for everyone aged 6 months or ...
Despite the general easing of restrictions, the pandemic isn’t over. Most vaccinated people will find the biggest risk is reinfection this winter.
U.S. health regulators will not require companies to submit new clinical trial data on COVID-19 vaccines that target the now ...